<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04606290</url>
  </required_header>
  <id_info>
    <org_study_id>O2matic-HOT1</org_study_id>
    <nct_id>NCT04606290</nct_id>
  </id_info>
  <brief_title>Automated Oxygen Titration With O2matic Home Oxygen Therapy (O2matic HOT) Phase 1</brief_title>
  <acronym>O2matic-HOT1</acronym>
  <official_title>Automated Oxygen Titration to Patients With COPD and Domiciliary Long-term Oxygen Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Innovation Fund Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Naestved Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      O2matic HOT is a further development of O2matic and is intended for home oxygen use with&#xD;
      patients in need of long-term oxygen treatment (LTOT). O2matic HOT is a closed-loop system&#xD;
      which on basis of signals from pulse oximetry titrates the oxygen flow to the patient. In&#xD;
      this crossover trial patients are admitted for 24 hours twice. Once with usual fixed dose&#xD;
      oxygen and once with oxygen titration by O2matic HOT.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to examine if automated oxygen control based on pulse oximetry&#xD;
      to patients with domiciliary long-term oxygen treatment (LTOT) is better than manually&#xD;
      controlled oxygen treatment in keeping SpO2 within intended target interval. In manually&#xD;
      controlled oxygen treatment flow is usually kept constant for months between visits from&#xD;
      specialist nurse, whereas in automated control the patient can titrate oxygen flow several&#xD;
      times a day based on pulse oximetry in a closed-loop system.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 28, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of time in intended SpO2-interval</measure>
    <time_frame>24 hours</time_frame>
    <description>Percentage of time with SpO2 in intended interval</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of time with SpO2 below 85 %</measure>
    <time_frame>24 hours</time_frame>
    <description>Percentage of time with SpO2 below 85 %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of time with SpO2 below target but not below 85 %</measure>
    <time_frame>24 hours</time_frame>
    <description>Percentage of time with SpO2 below target but not below 85 %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of time with SpO2 above target</measure>
    <time_frame>24 hours</time_frame>
    <description>Percentage of time with SpO2 above target</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in PaCO2 from baseline</measure>
    <time_frame>8 hours</time_frame>
    <description>Change in PaCO2 from baseline to 8 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in PaCO2 from baseline</measure>
    <time_frame>24 hours</time_frame>
    <description>Change in PaCO2 from baseline to 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accumulated oxygen usage</measure>
    <time_frame>24 hours</time_frame>
    <description>Accumulated oxygen usage in 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse and serious adverse events</measure>
    <time_frame>24 hours</time_frame>
    <description>Adverse and serious adverse events, such as respiratory acidosis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>COPD</condition>
  <condition>Chronic Hypoxemic Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Manual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fixed dose oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>O2matic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Automated oxygen titration</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>O2matic HOT</intervention_name>
    <description>Automated oxygen titration with O2matic HOT</description>
    <arm_group_label>O2matic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oxygen concentrator</intervention_name>
    <description>Fixed dose oxygen flow from concentrator</description>
    <arm_group_label>Manual</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Verified COPD with FEV1/FVC &lt; 0.70&#xD;
&#xD;
          -  Need of LTOT (PaO2 &lt;= 7.3 kPa or SpO2 &lt; 88 % on ambient air)&#xD;
&#xD;
          -  Cognitively able to participate&#xD;
&#xD;
          -  Willing to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Moderate or severe exacerbation in COPD within 4 weeks from study start&#xD;
&#xD;
          -  Major comorbidities (cancer, uncontrolled chronic disease)&#xD;
&#xD;
          -  Asthma or other disease with need of higher SpO2&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Fall in pH below 7.35 or increase in PaCO2 &gt; 1 kPa on 5 liters of oxygen&#xD;
&#xD;
          -  Active smoking&#xD;
&#xD;
          -  LTOT use less than 1 hours/day&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Ringbaek, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hvidovre University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ejvind F Hansen, MD</last_name>
    <phone>+4551221353</phone>
    <email>ejvind.frausing.hansen@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Uffe Boedtker, PhD</last_name>
    <phone>+4556514592</phone>
    <email>ubt@regionsjaelland.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hvidovre University Hospital</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ejvind Frausing Hansen, MD</last_name>
      <phone>+45 3862 3233</phone>
      <email>ejvind.frausing.hansen@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Susanne Wiemann, RN</last_name>
      <email>susanne.wiemann@regionh.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Lise-lotte Elkjaer Nielsen, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Næstved University Hospital</name>
      <address>
        <city>Næstved</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uffe Boedtker, PhD</last_name>
      <phone>+4556514592</phone>
      <email>ubt@regionsjaelland.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 24, 2020</study_first_submitted>
  <study_first_submitted_qc>October 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2020</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hvidovre University Hospital</investigator_affiliation>
    <investigator_full_name>Ejvind Frausing Hansen</investigator_full_name>
    <investigator_title>Chief Physician</investigator_title>
  </responsible_party>
  <keyword>O2matic</keyword>
  <keyword>Closed-loop</keyword>
  <keyword>Pulse oximetry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

